1887

Abstract

The nature of the inhibitor in guinea-pig serum and its mechanism of neutralization of influenza virus have been investigated. This inhibitor was shown to be a mannosebinding lectin serologically related to human serum mannose-binding protein. Ca-dependent binding of the guinea-pig lectin to influenza virus or to mannan could be detected with polyclonal or monoclonal antibodies against human mannose-binding protein in an ELISA. Furthermore, the monoclonal antibody inhibited both the haemagglutination-inhibiting and virus-neutralizing activities of the guinea-pig lectin. The lectin was active against influenza viruses of both type A and type B. In haemagglutination inhibition it acts independently of complement, apparently by sterically hindering access to the receptor-binding site on the viral haemagglutinin through binding of the lectin to carbohydrate side-chains in the vicinity of this site. Neutralization by the lectin, however, was shown to require activation of the classical complement pathway. To our knowledge, the neutralization of influenza virus by a serum lectin plus complement represents a previously unrecognized mechanism of complement-dependent viral inactivation that may be important in first-line host defence against a variety of enveloped viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-3-615
1994-03-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/3/JV0750030615.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-3-615&mimeType=html&fmt=ahah

References

  1. Anders E. M., Scalzo A. A., Rogers G. N., White D. O. 1986; Relationship between mitogenic activity of influenza viruses and the receptor binding specificity of their hemagglutinin molecules. Journal of Virology 60:476–482
    [Google Scholar]
  2. Anders E. M., Hartley C. A., Jackson D. C. 1990; Bovine and mouse serum β inhibitors of influenza A viruses are mannose-binding lectins. Proceedings of the National Academy of Sciences, U.S.A 87:4485–4489
    [Google Scholar]
  3. Baatrup G., Thiel S., Isager H., Svehag S.-E., Jensenius J. C. 1987; Demonstration in human plasma of a lectin activity analogous to that of bovine conglutinin. Scandinavian Journal of Immunology 26:355–361
    [Google Scholar]
  4. Beebe D. B., Cooper N. R. 1981; Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. Journal of Immunology 126:1562–1568
    [Google Scholar]
  5. Briody B. A., Cassel W. A., Medill M. A. 1955; Adaptation of influenza virus to mice. III. Development of resistance to beta-inhibitor. Journal of Immunology 74:41–45
    [Google Scholar]
  6. Childs R. A., Drickamer K., Kawasaki T., Thiel S., Mizuochi T., Feizi T. 1989; Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochemical Journal 262:131–138
    [Google Scholar]
  7. Chu C. M. 1951; The action of normal mouse serum on influenza virus. Journal of General Microbiology 5:739–757
    [Google Scholar]
  8. Cooper N. R., Jensen F. C., Welsh R. M., Oldstone M. B. A. 1976; Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement path-way. Journal of Experimental Medicine 144:970–984
    [Google Scholar]
  9. Cooper P. D., Carter M. 1986; Anticomplementary action of polymorphic solubility forms of particulate inulin. Molecular Immunology 23:895–901
    [Google Scholar]
  10. Dimmock N. J. 1987; Multiple mechanisms of neutralization of animal viruses. Trends in Biochemical Sciences 12:70–75
    [Google Scholar]
  11. Ezekowitz R. A. B. 1991; Ante-antibody immunity. Current Biology 1:60–62
    [Google Scholar]
  12. Ezekowitz R. A. B., Kuhlman M., Groopman J. E., Byrn R. A. 1989; A human serum mannose-binding protein inhibits infection by the human immunodeficiency virus. Journal of Experimental Medicine 169:185–196
    [Google Scholar]
  13. Haagsman H. P., Hawgood S., Sargeant T., Buckley D., White R. T., Drickamer K., Benson B. J. 1987; The major lung surfactant protein, SP28-36, is a calcium-dependent, carbohydratebinding protein. Journal of Biological Chemistry 262:13877–13880
    [Google Scholar]
  14. Hartley C. A., Jackson D. C., Anders E. M. 1992; Two distinct serum mannose-binding lectins function as β inhibitors of influenza virus: identification of bovine serum β inhibitor as conglutinin. Journal of Virology 66:4358–4363
    [Google Scholar]
  15. Hartshorn K. L., Sastry K., White M. R., Anders E. M., Super M., Ezekowitz R. A. B., Tauber A. I. 1993; Human mannosebinding protein functions as an opsonin for influenza viruses. Journal of Clinical Investigation 91:1414–1420
    [Google Scholar]
  16. Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., Yamashina I. 1987; Serum lectin with known structure activates complement through the classical pathway. Journal of Biological Chemistry 262:7451–7454
    [Google Scholar]
  17. Kawasaki N., Kawasaki T., Yamashina I. 1983; Isolation and characterization of a mannan-binding protein from human serum. Journal of Biochemistry 94:937–947
    [Google Scholar]
  18. Kawasaki N., Kawasaki T., Yamashina I. 1985; Mannan-binding protein and conglutinin in bovine serum. Journal of Biochemistry 98:1309–1320
    [Google Scholar]
  19. Kawasaki N., Kawasaki T., Yamashina I. 1989; A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. Journal of Biochemistry 106:483–489
    [Google Scholar]
  20. Kozutsumi Y., Kawasaki T., Yamashina I. 1980; Isolation and characterization of a mannan-binding protein from rabbit serum. Biochemical and Biophysical Research Communications 95:658–664
    [Google Scholar]
  21. Krizanova O., Rathova V. 1969; Serum inhibitors of myxoviruses. Current Topics in Microbiology and Immunology 47:125–151
    [Google Scholar]
  22. Lachmann P. J. 1967; Conglutinin and immunoconglutinins. Advances in Immunology 6:479–527
    [Google Scholar]
  23. Lachmann P. J., Hobart M. J. 1978; Complement technology. In Handbook of Experimental Immunology, 3rd edition. pp. 5A.1–5A.23 Weir D. M. Edited by Oxford: Blackwell Scientific Publications;
    [Google Scholar]
  24. Larkin M., Childs R. A., Matthews T. J., Thiel S., Mizuochi T., Lawson A. M., Savill J. S., Haslett C., Diaz R., Feizi T. 1989; Oligosaccharide-mediated interactions of the envelope glycoprotein gpl20 of HIV-1 that are independent of CD4 recognition. AIDS 3:793–798
    [Google Scholar]
  25. Linscott W. D., Levinson W. E. 1969; Complement components required for virus neutralization by early immunoglobulin antibody. Proceedings of the National Academy of Sciences, U.S.A 64:520–527
    [Google Scholar]
  26. Lu J., Thiel S., Wiedemann H., Timpl R., Reid K. B. M. 1990; Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme Clr2Cls2 complex of the classical pathway of complement, without involvement of Clq. Journal of Immunology 144:2287–2294
    [Google Scholar]
  27. Matsushita M., Fujita T. 1992; Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. Journal of Experimental Medicine 176:1497–1502
    [Google Scholar]
  28. Nelson B., Ruddy S. 1979; Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement. Journal of Immunology 122:1994–1999
    [Google Scholar]
  29. Ohta M., Okada M., Yamashina I., Kawasaki T. 1990; The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. Journal of Biological Chemistry 265:1980–1984
    [Google Scholar]
  30. Oka S., Ikeda K., Kawasaki T., Yamashina I. 1988; Isolation and characterization of two distinct mannan-binding proteins from rat serum. Archives of Biochemistry and Biophysics 260:257–266
    [Google Scholar]
  31. Oldstone M. B. A., Cooper N. R., Larson D. L. 1974; Formation and biological role of polyoma virus-antibody complexes: a critical role for complement. Journal of Experimental Medicine 140:549–565
    [Google Scholar]
  32. Oroszlan S., Gilden R. V. 1970; Immune virolysis: effect of antibody and complement on C-type RNA virus. Science 168:1478–1480
    [Google Scholar]
  33. Parham P. 1983; On the fragmentation of monoclonal IgGl, IgG2a, and IgG2b from BALB/c mice. Journal of Immunology 131:2895–2902
    [Google Scholar]
  34. Pritchett T. J., Paulson J. C. 1989; Basis for the potent inhibition of influenza virus infection by equine and guinea pig α2-macroglobulin. Journal of Biological Chemistry 264:9850–9858
    [Google Scholar]
  35. Radwan A. I., Craweord T. B. 1974; The mechanisms of neutralization of sensitized equine arteritis virus by complement components. Journal of General Virology 25:229–237
    [Google Scholar]
  36. Rust K., Grosso L., Zhang V., Chang D., Persson A., Longmore W., Cai G. Z., Crouch E. 1991; Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain. Archives of Biochemistry and Biophysics 290:116–126
    [Google Scholar]
  37. Ryan-Poirier K., Kawaoka Y. 1991; Distinct glycoprotein inhibitors of influenza A virus in different animal sera. Journal of Virology 65:389–395
    [Google Scholar]
  38. Schweinle J. E., Ezekowitz R. A. B., Tenner A. J., Kuhlman M., Joiner K. A. 1989; Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. Journal of Clinical Investigation 84:1821–1829
    [Google Scholar]
  39. Shimizu H., Fisher J. H., Papst P., Benson B., Lau K., Mason R. J., Voelker D. E. 1992; Primary structure of rat pulmonary surfactant protein D cDNA and deduced amino acid sequence. Journal of Biological Chemistry 267:1853–1857
    [Google Scholar]
  40. Spear G. T., Sullivan B. L., Takefman D. M., Landay A. L., Lint T. F. 1991; Human immunodeficiency virus (HlV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea pig sera; activation results in virus neutralization by virolysis. Immunology 73:377–382
    [Google Scholar]
  41. Strang C. J., Slayter H. S., Lachmann P. J., Davis A. E. III 1986; Ultrastructure of bovine conglutinin. Biochemical Journal 234:381–389
    [Google Scholar]
  42. Summerfield J. A., Taylor M. E. 1986; Mannose-binding proteins in human serum: identification of mannose-specific immuno-globulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochimica et biophysica acta 883:197–206
    [Google Scholar]
  43. Super M., Gillies S. D., Foley S., Sastry K., Schweinle J. E., Silverman V. J., Ezekowitz R. A. B. 1992; Distinct and overlapping functions of allelic forms of human mannose-binding protein. Nature Genetics, London 2:50–55
    [Google Scholar]
  44. Sweet C., Smith H. 1980; Pathogenicity of influenza virus. Microbiological Reviews 44:303–330
    [Google Scholar]
  45. Thiel S., Reid K. B. M. 1989; Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Letters 250:78–84
    [Google Scholar]
  46. Yamamoto F., Maeno K., Shibata S., Iinuma M., Miyama A., Kawamoto Y. 1987; Inactivation of influenza B virus by normal guinea-pig serum. Journal of General Virology 68:1135–1141
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-3-615
Loading
/content/journal/jgv/10.1099/0022-1317-75-3-615
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error